5-14601049-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019018.3(OTULINL):āc.149T>Cā(p.Leu50Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_019018.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTULINL | NM_019018.3 | c.149T>C | p.Leu50Ser | missense_variant | 2/8 | ENST00000274217.4 | NP_061891.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTULINL | ENST00000274217.4 | c.149T>C | p.Leu50Ser | missense_variant | 2/8 | 1 | NM_019018.3 | ENSP00000274217 | P1 | |
OTULINL | ENST00000513825.1 | n.85T>C | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251344Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135840
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461578Hom.: 0 Cov.: 33 AF XY: 0.0000179 AC XY: 13AN XY: 727046
GnomAD4 genome AF: 0.000289 AC: 44AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.149T>C (p.L50S) alteration is located in exon 2 (coding exon 2) of the FAM105A gene. This alteration results from a T to C substitution at nucleotide position 149, causing the leucine (L) at amino acid position 50 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at